BofA’s Hartnett says concentrated U.S. stock returns are likely to persist
Investing.com - Oppenheimer has raised its price target on Beyond Meat Inc . (NASDAQ:BYND) to $2.83 from $2.78 while maintaining a Perform rating on the stock. According to InvestingPro data, the stock has declined over 25% in the past six months, with analyst targets ranging from $2.00 to $5.00.
The firm cited Beyond Meat’s "soft" second-quarter results, noting that the plant-based meat alternative company continues to search for top-line stabilization amid challenging demand conditions. The company’s revenue declined 2.2% over the last twelve months, with gross margins at just 12%.
Oppenheimer highlighted that Beyond Meat is taking significant steps to improve its margins, but emphasized that much of this progress depends on achieving better visibility for its revenue outlook.
Beyond the profit and loss statement, the research firm identified liquidity as an ongoing concern, pointing specifically to the $1.1 billion debt on Beyond Meat’s balance sheet.
Despite the slight price target increase, Oppenheimer maintained its Hold rating on Beyond Meat shares, indicating a neutral stance on the stock’s near-term performance prospects.
In other recent news, Beyond Meat reported its financial results for the second quarter of 2025, highlighting a challenging period for the company. The company posted an earnings per share (EPS) of -$0.40, which was slightly below the forecast of -$0.38. Beyond Meat also generated $75 million in revenue, falling short of the $83.75 million that analysts had expected. These results reflect ongoing struggles with profitability and market conditions. The revenue miss and earnings figures have raised concerns among investors about the company’s financial performance. There were no reported mergers or acquisitions in this period. Analyst firms have yet to provide any upgrades or downgrades in response to these developments. Beyond Meat’s recent performance has been a focal point for investors monitoring the company’s ongoing financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.